In its efforts to promote nighttime tourism, the Tokyo Metropolitan Government is developing new attractions that illuminate the capital after dark. As part of this initiative, projection mapping is being presented year-round on the iconic Tokyo Metropolitan Government Building No. 1, transforming its façade into a canvas of light and sound. We are pleased to announce the launch of a new projection mapping show inspired by the globally beloved Pokémon Trading Card Game, which celebrates its 30t...

Kao Corporation (TOKYO:4452) today announced that its skincare brand Bioré will accelerate its international expansion as it enters the South Korean market and rolls out a globally unified campaign. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318478193/en/Image of Bioré & Stray Kids As a core brand under Kao’s “Global Sharp Top” strategy—aimed at establishing leadership in key market segments through high-value products—Bi...

Global energy technology company SLB (NYSE: SLB) today announced an expansion of its technology collaboration with NVIDIA to design and deploy critical AI infrastructure and models for the energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260324731936/en/SLB’s technology center in Louisiana: a 3.1 million square-foot facility dedicated to manufacturing for its modular data center business. The work focuses on three str...

Maven Investment Partners Ltd. Hong Kong Branch (“Maven”), one of the largest minority shareholders of MCJ Co., Ltd (“MCJ” or the “Company”) with a stake close to 3%, published a letter today addressed to all shareholders of the Company concerning the unfair terms of the tender offer (“Offer”) by BCPE Meta Cayman, L.P. (“Bain”) for MCJ. Maven confirms it has no intention of tendering into the Offer on current terms, which it views as an egregious disregard for fair M&A in Japan and an end...

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the o...

LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506065669/...

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507251188/en/Global commerce intelligence platform delivers high employee satisfaction with Navan Criteo set out to provide its global workforce with an easy-to-use tra...

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its fourth quarter and full year 2025 results on Wednesday, April 1, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts, and market makers on the OCP Intralinks portal from 9:00 a.m. EST, 2:00 p.m. Morocco and London time (GMT+1). OCP senior management will host a conference call to discuss fourth quarter and full year 2025 results...